Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia
Eugen Tausch,
William Close,
Anna Dolnik,
Johannes Bloehdorn,
Brenda Chyla,
Lars Bullinger,
Hartmut Döhner,
Daniel Mertens,
Stephan Stilgenbauer
Affiliations
Eugen Tausch
Department of Internal Medicine III, Ulm University, Ulm, Germany
William Close
Department of Internal Medicine III, Ulm University, Ulm, Germany
Anna Dolnik
Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany
Johannes Bloehdorn
Department of Internal Medicine III, Ulm University, Ulm, Germany
Brenda Chyla
AbbVie, North Chicago, IL, USA
Lars Bullinger
Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany
Hartmut Döhner
Department of Internal Medicine III, Ulm University, Ulm, Germany
Daniel Mertens
Department of Internal Medicine III, Ulm University, Ulm, Germany;Cooperation unit “Mechanisms of Leukemogenesis”, Deutsches Krebsforschungszentrum DKFZ, Heidelberg, Germany
Stephan Stilgenbauer
Department of Internal Medicine III, Ulm University, Ulm, Germany;Department for Hematology, Oncology and Rheumatology, Saarland University Medical School, Homburg/Saar, Germany
